<- Go Home
YD Bio Limited
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Market Cap
$861.4M
Volume
5.8K
Cash and Equivalents
$3.1M
EBITDA
-$1.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$155.4K
Profit Margin
30.44%
52 Week High
$31.00
52 Week Low
$5.30
Dividend
N/A
Price / Book Value
2.68
Price / Earnings
-9.50
Price / Tangible Book Value
4.52
Enterprise Value
$858.3M
Enterprise Value / EBITDA
-640.48
Operating Income
-$1.5M
Return on Equity
42.69%
Return on Assets
-25.43
Cash and Short Term Investments
$3.1M
Debt
$22.3K
Equity
$6.6M
Revenue
$510.4K
Unlevered FCF
-$3.9M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium